Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 9:51 AM UTC
| NCT Number | NCT07023627 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | PHASE2 |
| Target Enrollment | 160 participants |
| Active Locations | 38 sites in the US |
| Sponsor | Incyte Corporation |
| Last Updated on CT.gov | September 15, 2026 (Sep 15, 2026) |
As of October 16, 2026: Clinical trial NCT07023627 is currently recruiting participants. This phase2 study for ovarian cancer is actively seeking new participants at 38 locations across the United States. The study is sponsored by Incyte Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07023627 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 38 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07023627 was last updated Sep 15, 2026 (September 15, 2026). HelloStudys verifies this status automatically.